Shigeo Ichihashi

Shigeo Ichihashi

Auto-generated profile, based on publicly available information

Shigeo Ichihashi

Department of Diagnostic and Interventional Radiology, Nara Medical University, Nara, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SIShigeo Ichihashi
Shigeo Ichihashi
WHWataru Higashiura
Wataru Higashiura
HIHirofumi Itoh
Hirofumi Itoh
SSShoji Sakaguchi
Shoji Sakaguchi
KNKiyoshi Nishimine
Kiyoshi Nishimine
KKKimihiko Kichikawa
Kimihiko Kichikawa

1 December 2015 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SIShinichi Iwakoshi
Shinichi Iwakoshi
SIShigeo Ichihashi
Shigeo Ichihashi
HIHirofumi Itoh
Hirofumi Itoh
NTNobuoki Tabayashi
Nobuoki Tabayashi
SSShoji Sakaguchi
Shoji Sakaguchi
KKKimihiko Kichikawa
Kimihiko Kichikawa

25 February 2016 in Hypertension Research
Verified
Journal Article
Closed access
THTomoko Hashimoto
Tomoko Hashimoto
SIShigeo Ichihashi
Shigeo Ichihashi
SIShinichi Iwakoshi
Shinichi Iwakoshi
KKKimihiko Kichikawa
Kimihiko Kichikawa

1 May 2014 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
SIShigeo Ichihashi
Shigeo Ichihashi
TSTomoyasu Sato
Tomoyasu Sato
SIShinichi Iwakoshi
Shinichi Iwakoshi
HIHirofumi Itoh
Hirofumi Itoh
KKKimihiko Kichikawa
Kimihiko Kichikawa

1 July 2019 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
SIShigeo Ichihashi
Shigeo Ichihashi
TSTsuyoshi Shibata
Tsuyoshi Shibata
NFNaoki Fujimura
Naoki Fujimura
SNSatoru Nagatomi
Satoru Nagatomi
HYHiroshi Yamamoto
Hiroshi Yamamoto
KKKimihiko Kichikawa
Kimihiko Kichikawa
Purpose: To evaluate the effect of vessel calcification on in-stent restenosis (ISR) after drug-coated stent (DCS) placement in the femoropopliteal segment. Materials and Methods: A retrospective multicenter study was undertaken involving 220 consecutive symptomatic patients (mean age 73.1±8.3 years; 175 men) with femoropopliteal lesions in 230 limbs treated with the Zilver PTX DCS and having duplex surveillance after the endovascular procedures. Mean lesion length was 16.4±9.8 cm (range 2–40); there were 104 (45.2%) total occlusions and 68 (29.6%) in-stent restenoses (ISR). Twenty (8.7%) vessels had no runoff. The majority of lesions (148, 64.3%) were calcified according to the peripheral arterial calcium scoring system (PACSS). Primary patency was evaluated by duplex. Lesions were classified as either PACSS 0–2 (none or unilateral wall calcification) or PACSS 3 and 4 (bilateral wall calcification). Multivariate analysis was performed to identify variables associated with ISR; the results are given as the hazard ratio (HR) and 95% confidence interval (CI). Results: The 1-, 2-, and 5-year primary patency and freedom from clinically-driven target lesion revascularization estimates were 75.9%, 63.6%, and 45.0%, and 84.7%, 73.7%, and 54.2%, respectively. Major amputations were performed on 4 limbs during follow-up. In multivariate analysis, vessel calcification (adjusted HR 1.718, 95% CI 1.035 to 2.851, p=0.036) was significantly correlated with the occurrence of ISR, along with lesion length (adjusted HR 1.041, 95% CI 1.013 to 1.070, p=0.003), and cilostazol administration (adjusted HR 0.476, 95% CI 0.259 to 0.876, p=0.017). Conclusion: This study suggested that bilateral vessel wall calcification was an independent risk factor for ISR in complex femoropopliteal lesions after Zilver PTX DCS placement, along with lesion length; cilostazol administration had a protective effect.

13 April 2018 in Cardiovascular Intervention and Therapeutics
Verified
Journal Article
Open access
PDF file
OKOsami Kawarada
Osami Kawarada
KZKan Zen
Kan Zen
KHKoji Hozawa
Koji Hozawa
SAShinobu Ayabe
Shinobu Ayabe
HHHsuan-Li Huang
Hsuan-Li Huang
HOHideaki Obara
Hideaki Obara
The burden of peripheral artery disease (PAD) and diabetes in Asia is projected to increase. Asia also has the highest incidence and prevalence of end-stage renal disease (ESRD) in the world. Therefore, most Asian patients with PAD might have diabetic PAD or ESRD-related PAD. Given these pandemic conditions, critical limb ischemia (CLI) with diabetes or ESRD, the most advanced and challenging subset of PAD, is an emerging public health issue in Asian countries. Given that diabetic and ESRD-related CLI have complex pathophysiology that involve arterial insufficiency, bacterial infection, neuropathy, and foot deformity, a coordinated approach that involves endovascular therapy and wound care is vital. Recently, there is increasing interaction among cardiologists, vascular surgeons, radiologists, orthopedic surgeons, and plastic surgeons beyond specialty and country boundaries in Asia. This article is intended to share practical Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care for CLI.